skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes a systematic overview
Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes a systematic overview
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes a systematic overview

John L. Petersen Kenneth W Mahaffey; Vic Hasselblad; Elliott M Antman; Marc Cohen; Shaun G Goodman; Anatoly Langer; Michael A Blazing; Anne Le-Moigne-Amrani; James A. de Lemos; Christopher C Nessel; Robert A Harrington; James J Ferguson; Eugene Braunwald; Robert M Califf; José Antônio Marin-Neto

JAMA Chicago v. 292, n. 1, p. 89-96, 2004

Chicago 2004

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1401138 )(Acessar)

2
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes Phase Z of the A to Z trial
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes Phase Z of the A to Z trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes Phase Z of the A to Z trial

James A. Lemos Michael A Blazing; Stephen D Wiviott; Eldrin F Lewis; Keith A. A Fox; Harvey D White; Jean-Lucien Rouleau; Terje Pedersen; Laura H Gardner; Robin Mukherjee; Karen E Ramsey; Joanne Palmisano; David W Bilheimer; Marc A Pfeffer; Robert M Califf; Eugene Braunwald; José Antônio Marin-Neto

JAMA Chicago, 2004 v. 292, n. 11, p. 1307-1316, 2004

Chicago 2004

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1436209 )(Acessar)

3
Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes a systematic overview
Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes a systematic overview
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes a systematic overview

John L. Petersen Kenneth W Mahaffey; Vic Hasselblad; Elliott M Antman; Marc Cohen; Shaun G Goodman; Anatoly Langer; Michael A Blazing; Anne Le-Moigne-Amrani; James A. de Lemos; Christopher C Nessel; Robert A Harrington; James J Ferguson; Eugene Braunwald; Robert M Califf; José Antônio Marin-Neto

JAMA Chicago v. 292, n. 1, p. 89-96, 2004

Chicago 2004

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1401138 )(Acessar)

4
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes Phase Z of the A to Z trial
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes Phase Z of the A to Z trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes Phase Z of the A to Z trial

James A. Lemos Michael A Blazing; Stephen D Wiviott; Eldrin F Lewis; Keith A. A Fox; Harvey D White; Jean-Lucien Rouleau; Terje Pedersen; Laura H Gardner; Robin Mukherjee; Karen E Ramsey; Joanne Palmisano; David W Bilheimer; Marc A Pfeffer; Robert M Califf; Eugene Braunwald; José Antônio Marin-Neto

JAMA Chicago, 2004 v. 292, n. 11, p. 1307-1316, 2004

Chicago 2004

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1436209 )(Acessar)

5
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin A randomized controlled trial
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin A randomized controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin A randomized controlled trial

Michael A. Blazing James A. de Lemos; Harvey White; Keith A. A Fox; Freek W. A Verheugt; Diego Ardissino; Peter M DiBattiste; Joanne Palmisano; David W Bilheimer; Steven M Snapinn; Karen E Ramsey; Laura H Gardner; Vic Hasselblad; Marc A Pfeffer; Eldrin F Lewis; Eugene Braunwald; Robert M Califf; José Antônio Marin-Neto

JAMA Chicago 2004

Chicago 2004

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1400697 )(Acessar)

6
Ezetimibe added to statin therapy after acute coronary syndromes
Ezetimibe added to statin therapy after acute coronary syndromes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ezetimibe added to statin therapy after acute coronary syndromes

Christopher P. Cannon Michael A Blazing; Robert P Giugliano; Amy McCagg; Jennifer A White; Pierre Theroux; Harald Darius; Basil S Lewis; Ton Oude Ophuis; J. Wouter Jukema; Gaetano M. De Ferrari; Witold Ruzyllo; Paul De Lucca; KyungAh Im; Erin A Bohula; Craig Reist; Stephen D Wiviott; Andrew M Tershakovec; Thomas A Musline; Eugene Braunwald; Robert M Califf; José Antonio Marin Neto; André Schmidt; IMPROVE-IT Investigators

The New England Journal of Medicine Waltham v. 372, n. 25, p. 2387-2397, 2015

Waltham 2015

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 2762049 Estantes Deslizantes )(Acessar)

7
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin A randomized controlled trial
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin A randomized controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin A randomized controlled trial

Michael A. Blazing James A. de Lemos; Harvey White; Keith A. A Fox; Freek W. A Verheugt; Diego Ardissino; Peter M DiBattiste; Joanne Palmisano; David W Bilheimer; Steven M Snapinn; Karen E Ramsey; Laura H Gardner; Vic Hasselblad; Marc A Pfeffer; Eldrin F Lewis; Eugene Braunwald; Robert M Califf; José Antônio Marin-Neto

JAMA Chicago 2004

Chicago 2004

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1400697 )(Acessar)

8
Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention
Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention
Material Type:
Artigo 		Adicionar ao Meu Espaço

Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention

Bohula, Erin A., MD, DPhil ; Morrow, David A., MD, MPH ; Giugliano, Robert P., MD, SM ; Blazing, Michael A., MD ; He, Ping, MS ; Park, Jeong-Gun, PhD ; Murphy, Sabina A., MPH ; White, Jennifer A., MS ; Kesaniemi, Y. Antero, MD, PhD ; Pedersen, Terje R., MD, PhD ; Brady, Adrian J., MD ; Mitchel, Yale, MD ; Cannon, Christopher P., MD ; Braunwald, Eugene, MD

Journal of the American College of Cardiology, 2017-02, Vol.69 (8), p.911-921 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
9
Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations
Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations

Shah, Nishant P. ; Pajidipati, Neha J. ; McGarrah, Robert W. ; Navar, Ann Marie ; Vemulapalli, Sreekanth ; Blazing, Michael A. ; Shah, Svati H. ; Hernandez, Adrian F. ; Patel, Manesh R.

The American journal of cardiology, 2020-07, Vol.126, p.94-102 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
10
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population

Blazing, Michael A., MD ; Giugliano, Robert P., MD, SM ; Cannon, Christopher P., MD ; Musliner, Thomas A., MD ; Tershakovec, Andrew M., MD, MPH ; White, Jennifer A., MS ; Reist, Craig, PhD ; McCagg, Amy, BS ; Braunwald, Eugene, MD ; Califf, Robert M., MD

The American heart journal, 2014-08, Vol.168 (2), p.205-212.e1 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1999  (13)
  2. 1999Até2004  (33)
  3. 2005Até2010  (23)
  4. 2011Até2018  (33)
  5. Após 2018  (22)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.